Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups
Shiv Chitturi, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, et al.
Journal of Gastroenterology and Hepatology (2017) Vol. 33, Iss. 1, pp. 86-98
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El‐Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1328
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Pοlyzos, Јannis Kountouras, Christos S. Mantzoros
Metabolism (2018) Vol. 92, pp. 82-97
Closed Access | Times Cited: 947
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
Vincent Wai‐Sun Wong, Leon A. Adams, Victor de Lédinghen, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 8, pp. 461-478
Closed Access | Times Cited: 527
Epidemiological Features of NAFLD From 1999 to 2018 in China
Jianghua Zhou, Feng Zhou, Wenxin Wang, et al.
Hepatology (2020) Vol. 71, Iss. 5, pp. 1851-1864
Closed Access | Times Cited: 525
Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 60-78
Open Access | Times Cited: 522
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Simona Leoni, Francesco Tovoli, Lucia Napoli, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 30, pp. 3361-3373
Open Access | Times Cited: 496
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
Feng Zhou, Jianghua Zhou, Wenxin Wang, et al.
Hepatology (2019) Vol. 70, Iss. 4, pp. 1119-1133
Closed Access | Times Cited: 463
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 397
Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
Dimitrios A. Koutoukidis, Nerys M. Astbury, Kate Tudor, et al.
JAMA Internal Medicine (2019) Vol. 179, Iss. 9, pp. 1262-1262
Open Access | Times Cited: 192
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 183
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
Jian‐Gao Fan, Lai Wei, Hui Zhuang
Journal of Digestive Diseases (2018) Vol. 20, Iss. 4, pp. 163-173
Closed Access | Times Cited: 175
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
Evangelia Makri, A. Goulas, Stergios A. Pοlyzos
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 25-37
Closed Access | Times Cited: 165
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
Chander K. Negi, Pavel Babica, Lola Bajard, et al.
Metabolism (2021) Vol. 126, pp. 154925-154925
Open Access | Times Cited: 163
Nonalcoholic Fatty Liver Disease and Recent Guideline Updates
Yukio Ando, Janice H. Jou
Clinical Liver Disease (2021) Vol. 17, Iss. 1, pp. 23-28
Open Access | Times Cited: 149
Management of non-alcoholic fatty liver disease
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, et al.
BMJ (2021), pp. m4747-m4747
Open Access | Times Cited: 147
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1069-1083
Open Access | Times Cited: 143
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
Piero Portincasa, Mohamad Khalil, Laura Mahdi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5640-5640
Open Access | Times Cited: 19
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 16
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 51, Iss. 8, pp. 801-811
Open Access | Times Cited: 122
History of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Simona Leoni, Khalid Alswat, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5888-5888
Open Access | Times Cited: 117
A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease
Muhammad Izzad Johari, Khairiah Yusoff, Juhara Haron, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Nonalcoholic fatty liver disease burden: Australia, 2019–2030
Leon A. Adams, Stuart K. Roberts, Simone I. Strasser, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 9, pp. 1628-1635
Open Access | Times Cited: 93
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
Zobair M. Younossi, Maria Stepanova, Quentin M. Anstee, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 17, Iss. 12, pp. 2552-2560.e10
Open Access | Times Cited: 78
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
Stergios A. Pοlyzos, Stergios Kechagias, Emmanuel Tsochatzis
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 8, pp. 1013-1025
Open Access | Times Cited: 78
A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease
John A. Dougherty, Erenie Guirguis, Krisy‐Ann Thornby
Annals of Pharmacotherapy (2020) Vol. 55, Iss. 1, pp. 65-79
Closed Access | Times Cited: 70
Page 1 - Next Page

Scroll to top